Luc Furic

12PUBLICATIONS
50CO-AUTHORS
Predictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsMedical molecular engineering of nucleic acids and proteins
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (12)

|Nov 19, 2025
Reply to: The chemotherapeutic drug CX-5461 is a potent mutagen in cultured human cells.

Sehrish Kanwal, Natalie Brajanovski, Jiajun Zhan

|Aug 20, 2021
The MURAL collection of prostate cancer patient-derived xenografts enables discovery through preclinical models of uro-oncology.

Gail P Risbridger, Ashlee K Clark, Laura H Porter

|Aug 20, 2021
CX-5461 Sensitizes DNA Damage Repair-proficient Castrate-resistant Prostate Cancer to PARP Inhibition.

Mitchell G Lawrence, Laura H Porter, Nicholas Choo

|Jul 02, 2021
Regulation of mRNA Translation by Hormone Receptors in Breast and Prostate Cancer.

Jianling Xie, Eric P Kusnadi, Luc Furic

|Apr 03, 2021
Mast Cell-Derived SAMD14 Is a Novel Regulator of the Human Prostate Tumor Microenvironment.

Linda K H Teng, Brooke A Pereira, Shivakumar Keerthikumar

Pageof 2